Boothbay Fund Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1559 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1602 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1546 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1605 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2082 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1980 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2155 |
|
|
2022
Q1 | – | Sell |
-2,885
| Closed | -$244K | – | 2069 |
|
|
2021
Q4 | $244K | Buy |
+2,885
| New | +$244K | 0.01% | 1212 |
|
|
2021
Q3 | – | Sell |
-2,542
| Closed | -$248K | – | 1838 |
|
|
2021
Q2 | $248K | Buy |
2,542
+78
| +3% | +$7.61K | 0.01% | 1233 |
|
|
2021
Q1 | $288K | Buy |
2,464
+119
| +5% | +$13.9K | 0.01% | 993 |
|
|
2020
Q4 | $261K | Hold |
2,345
| – | – | 0.01% | 843 |
|
|
2020
Q3 | $278K | Sell |
2,345
-16,890
| -88% | -$2M | 0.02% | 710 |
|
|
2020
Q2 | $2.18M | Sell |
19,235
-4,188
| -18% | -$474K | 0.15% | 143 |
|
|
2020
Q1 | $1.56M | Buy |
23,423
+8,000
| +52% | +$534K | 0.13% | 162 |
|
|
2019
Q4 | $1.41M | Buy |
15,423
+5,266
| +52% | +$480K | 0.12% | 193 |
|
|
2019
Q3 | $876K | Sell |
10,157
-882
| -8% | -$76.1K | 0.08% | 282 |
|
|
2019
Q2 | $1.16M | Buy |
11,039
+1,239
| +13% | +$130K | 0.11% | 182 |
|
|
2019
Q1 | $1.23M | Buy |
+9,800
| New | +$1.23M | 0.12% | 141 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 702 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 759 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 723 |
|